Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,788.00    -94.00 (-1.93%)
Bid:
4,780.00
Ask:
4,782.00
Spread: 2.00 (0.042%)
Market Cap: £2.23b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
7th Apr 200812:34 pmRNSDirector/PDMR Shareholding
4th Apr 20085:02 pmRNSTotal Voting Rights
31st Mar 20084:55 pmRNSHolding(s) in Company
27th Mar 200811:19 amRNSHolding(s) in Company
20th Mar 20087:00 amRNSMorgan Est GBP62.5m contract
13th Mar 20083:42 pmRNSHolding(s) in Company
11th Mar 20084:28 pmRNSDirector/PDMR Shareholding
6th Mar 20087:00 amRNSMorgan Est GBP445m contract
4th Mar 20085:16 pmRNSHolding(s) in Company
26th Feb 20084:18 pmRNSHolding(s) in Company
25th Feb 200810:57 amRNSHolding(s) in Company
19th Feb 20087:01 amRNSFinal Results
13th Feb 20085:13 pmRNSHolding(s) in Company
11th Feb 20082:41 pmRNSHolding(s) in Company
7th Feb 20084:36 pmRNSHolding(s) in Company
7th Feb 20087:47 amRNSHolding(s) in Company
5th Feb 20082:38 pmRNSHolding(s) in Company
1st Feb 20083:12 pmRNSHolding(s) in Company
1st Feb 20083:05 pmRNSHolding(s) in Company
28th Jan 20088:09 amRNSHolding(s) in Company
24th Jan 20083:42 pmRNSHolding(s) in Company
24th Jan 20087:58 amRNSHolding(s) in Company
21st Jan 200810:43 amRNSNotice of Results
15th Jan 20082:54 pmRNSHolding(s) in Company
11th Jan 200812:57 pmRNSHolding(s) in Company
9th Jan 20085:05 pmRNSHolding(s) in Company
2nd Jan 20083:35 pmRNSHolding(s) in Company
2nd Jan 20083:14 pmRNSHolding(s) in Company
21st Dec 20073:53 pmRNSTotal Voting Rights
21st Dec 20073:51 pmRNSDirector/PDMR Shareholding
21st Dec 20073:44 pmRNSHolding(s) in Company
20th Dec 200710:47 amRNSHolding(s) in Company
20th Dec 20077:01 amRNSDirector/PDMR Shareholding
18th Dec 200712:41 pmRNSHolding(s) in Company
14th Dec 200711:43 amRNSHolding(s) in Company
13th Dec 20077:01 amRNSPre Close Trading Statement
7th Dec 20073:23 pmRNSHolding(s) in Company
7th Dec 200711:40 amRNSHolding(s) in Company
5th Dec 200711:01 amRNSGBP 200 m Construction Prog
5th Dec 20078:24 amRNSHolding(s) in Company
30th Nov 20074:16 pmRNSHolding(s) in Company
30th Nov 20072:51 pmRNSDirector/PDMR Shareholding
30th Nov 20072:33 pmRNSTotal Voting Rights
28th Nov 20073:07 pmRNSDirector/PDMR Shareholding
27th Nov 20077:01 amRNSTrading Statement
31st Oct 20079:07 amRNSTotal Voting Rights
10th Oct 20078:40 amRNSHolding(s) in Company
5th Oct 200710:08 amRNSHolding(s) in Company
4th Oct 20077:02 amRNSMorgan Ashurst GBP25m scheme
28th Sep 20078:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.